Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
After-Hours: 20:00
Karyopharm Therapeutics Total Liabilities (Quarterly) : 401.34M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Baxter International, Inc. | 13.95B |
| Bruker Corp. | 3.731B |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Agios Pharmaceuticals, Inc. | 104.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.42M |
| Shareholders Equity (Quarterly) | -292.93M |
| Debt to Equity Ratio | -0.7746 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -5.20% |